Early treatment of reactive arthritis with etanercept and 2 years follow-up

被引：5
|
作者：
Courcoul, Audrey [1 ,2 ]
Pistor, Olivier Muis [1 ,2 ]
Tebib, Jacques G. [1 ,2 ]
Coury, Fabienne [1 ,2 ]
机构：
[1] Ctr Hosp Lyon Sud, Serv Rhumatol, F-69310 Pierre Benite, France
[2] Univ Claude Bernard Lyon, F-69622 Villeurbanne, France
来源：
JOINT BONE SPINE | 2017年 / 84卷 / 03期
关键词：
Reactive arthritis; TNF-alpha; INFLIXIMAB;
D O I：
10.1016/j.jbspin.2016.05.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：367 / 367
页数：1
相关论文
共 50 条
  • [21] 10 years follow-up of early corticosteroid treatment of Duchenne muscular dystrophy
    Merlini, L.
    Malaspina, E.
    Gennari, M.
    Cicognani, A.
    Franzoni, E.
    Talim, B.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 772 - 772
  • [22] Pharmacotherapeutic follow-up of patients with rheumatoid arthritis treated with etanercept complemented with a pharmacogenetic study
    Cristian Plaza, Jose
    Aguilera, Margarita
    Angel Calleja, Miguel
    PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 304 - 304
  • [23] INFLIXIMAB TREATMENT IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHROPATHIES: DRUG SURVIVAL AND REASONS FOR DISCONTINUATION DURING 2 YEARS OF FOLLOW-UP
    Levalampi, T.
    Korpela, M.
    Vuolteenaho, K.
    Moilanen, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2009, 38 (05) : 402 - 402
  • [24] Pregnancy and etanercept -: Two cases and follow-up
    Rump, JA
    Usadel, S
    Schönborn, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 182 - 183
  • [25] Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up
    Helga Raquel Garcia Ferrer
    Alexander Azan
    Isa Iraheta
    Joan Von Feldt
    Luis R. Espinoza
    Julia Manasson
    Jose U. Scher
    Abraham Garcia Kutzbach
    Alexis Ogdie
    Clinical Rheumatology, 2018, 37 : 415 - 422
  • [26] Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up
    Garcia Ferrer, Helga Raquel
    Azan, Alexander
    Iraheta, Isa
    Von Feldt, Joan
    Espinoza, Luis R.
    Manasson, Julia
    Scher, Jose U.
    Garcia Kutzbach, Abraham
    Ogdie, Alexis
    CLINICAL RHEUMATOLOGY, 2018, 37 (02) : 415 - 422
  • [27] TREATMENT OF OPIATE DEPENDENTS WITH NALTREXONA - 21/2 YEARS OF FOLLOW-UP
    OCHOA, E
    ARIAS, F
    SOMOZA, JC
    LOPEZIBOR, JJ
    ARCHIVOS DE NEUROBIOLOGIA, 1992, 55 (05): : 224 - 227
  • [28] THYROID SUPPRESSIBILITY - FOLLOW-UP FOR 2 YEARS AFTER ANTITHYROID TREATMENT
    LOWRY, RC
    LOWE, D
    HADDEN, DR
    MONTGOMERY, DA
    WEAVER, JA
    BMJ-BRITISH MEDICAL JOURNAL, 1971, 2 (5752): : 19 - +
  • [29] THYROID SUPPRESSIBILITY FOLLOW-UP FOR 2 YEARS AFTER ANTITHYROID TREATMENT
    MONTGOME.DA
    WEAVER, JA
    LOWE, DC
    HADDEN, DR
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1972, 8 (11): : 1891 - &
  • [30] Poststreptococcal reactive arthritis in adults:: Long-term follow-up
    Iglesias-Gamarra, A
    Mendez, EA
    Cuellar, ML
    De Leon, JHP
    Jimenez, C
    Cañas, C
    Restrepo, J
    Peña, M
    Valle, R
    Espinoza, LR
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2001, 321 (03): : 173 - 177
12345